Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of immune escape in the cancer immune cycle
Sha Tang, Qian Ning, Ling Yang, et al.
International Immunopharmacology (2020) Vol. 86, pp. 106700-106700
Closed Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
Shiv Kumar Sarin, Ashok Choudhury, George Lau, et al.
Hepatology International (2020) Vol. 14, Iss. 5, pp. 690-700
Open Access | Times Cited: 280
Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?
Cheng‐Liang Kuo, Ananth Ponneri Babuharisankar, Ying‐Chen Lin, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 169
Current Landscape of Non-Small Cell Lung Cancer: Epidemiology, Histological Classification, Targeted Therapies, and Immunotherapy
Olga Rodak, Manuel David Peris‐Díaz, Mateusz Olbromski, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4705-4705
Open Access | Times Cited: 143
Multifunctional nanoparticle for cancer therapy
Yan Gao, Kaiyu Wang, Jin Zhang, et al.
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 45
Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion
Junli Lu, Yiming Luo, Dean Rao, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 37
Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade
Young‐Jin Choi, Su Hyun Seok, Hong Yeol Yoon, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115306-115306
Open Access | Times Cited: 19
Exosomal lncRNA SNHG10 derived from colorectal cancer cells suppresses natural killer cell cytotoxicity by upregulating INHBC
Yi‐Wen Huang, Yanbo Luo, Wentao Ou, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 68
Recent Advances and Next Breakthrough in Immunotherapy for Cancer Treatment
Ling Yang, Qian Ning, Shengsong Tang
Journal of Immunology Research (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 55
Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy
Biao‐Qi Chen, Yi Zhao, Yang Zhang, et al.
Bioactive Materials (2022) Vol. 21, pp. 1-19
Open Access | Times Cited: 50
Enhancing the Efficiency of Mild-Temperature Photothermal Therapy for Cancer Assisting with Various Strategies
Pei Wang, Biao‐Qi Chen, Yunyan Zhan, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2279-2279
Open Access | Times Cited: 43
Tryptophan metabolism and disposition in cancer biology and immunotherapy
Abdulla A.‐B. Badawy
Bioscience Reports (2022) Vol. 42, Iss. 11
Open Access | Times Cited: 42
FOXP3/HAT1 Axis Controls Treg Infiltration in the Tumor Microenvironment by Inducing CCR4 Expression in Breast Cancer
Tania Sarkar, Subhanki Dhar, Dwaipayan Chakraborty, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
Multi-omics analysis: Paving the path toward achieving precision medicine in cancer treatment and immuno-oncology
Virgile Raufaste-Cazavieille, Raoul Santiago, Arnaud Droit
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 38
Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment
Rongyang Li, Bing Huang, Hui Tian, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 24
Cancer immune evasion through KRAS and PD-L1 and potential therapeutic interventions
Alex Watterson, Matthew A. Coelho
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Design, synthesis and anticancer evaluation of novel oncolytic peptide-chlorambucil conjugates
Hao Yin, Xing‐Yan Fu, Hanyu Gao, et al.
Bioorganic Chemistry (2023) Vol. 138, pp. 106674-106674
Closed Access | Times Cited: 22
Immunotherapy resistance in solid tumors: mechanisms and potential solutions
Daniel S. Lefler, Steven Manobianco, Babar Bashir
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 14
The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities
Bianca Garlisi, Sylvia Lauks, Caroline Aitken, et al.
Current Oncology (2024) Vol. 31, Iss. 7, pp. 3826-3844
Open Access | Times Cited: 11
Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion
Ankita Mitra, Anoop Kumar, Nitin Amdare, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 307-307
Open Access | Times Cited: 9
Granzymes in health and diseases: the good, the bad and the ugly
Lavinia Cigalotto, Denis Martinvalet
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Phospholipase A2 Drives Tumorigenesis and Cancer Aggressiveness through Its Interaction with Annexin A1
Lara Vecchi, Thaise Gonçalves Araújo, Fernanda Van Petten de Vasconcelos Azevedo, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1472-1472
Open Access | Times Cited: 55
Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential
Ya-Nan Pi, Wen-Cai Qi, Bairong Xia, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 52
The Scavenger Receptor MARCO Expressed by Tumor-Associated Macrophages Are Highly Associated With Poor Pancreatic Cancer Prognosis
Bian Shi, Junfeng Chu, Tao Huang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 50
Targeting STING for cancer immunotherapy: From mechanisms to translation
Ruilei Huang, Qian Ning, Jihui Zhao, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109304-109304
Closed Access | Times Cited: 33
The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy
Katarzyna Starska
Cancers (2023) Vol. 15, Iss. 6, pp. 1642-1642
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top